SCHEMBL25625879

SCHEMBL25625879

Cc1cnc(N[C@@H]2C[C@H]3CNC[C@H]3C2)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.51
▸ KDM1A O60341 1/20 0.50
▸ JAK2 O60674 1/20 0.44
▸ JAK1 P23458 1/20 0.44
▸ SYK P43405 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ CHRNB2 P17787 3/20 0.32
▸ CHRNB4 P30926 3/20 0.32
▸ CHRNA3 P32297 3/20 0.32
▸ CHRNA4 P43681 3/20 0.32
▸ CCNK O75909 3/20 0.32
▸ CDK12 Q9NYV4 3/20 0.32
▸ PCSK9 Q8NBP7 2/20 0.32
▸ CCNT1 O60563 2/20 0.31
▸ CDK9 P50750 2/20 0.31
▸ CCNE1 P24864 1/20 0.31
▸ CDK2 P24941 1/20 0.31
▸ CDK7 P50613 1/20 0.31
▸ CCNH P51946 1/20 0.31
▸ MNAT1 P51948 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25631508 0.79 KDM1A (0.45) KDM1AJAK2JAK1CHRNB2CHRNA4
SCHEMBL2369987 0.75 MAPK1 (0.75) MAPK1KDM4EGAAHDAC3HDAC1
SCHEMBL31736992 0.75 MAPK1 (0.64) MAPK1JAK2JAK1CDK2KDM4E
SCHEMBL25631498 0.75 DDB1 (0.43) KDM1AJAK2JAK1CHRNB2CHRNB4
SCHEMBL27362986 0.74 MAPK1 (0.53) MAPK1CCNKCDK12PCSK9
SCHEMBL10293575 0.72 MAPK1 (0.70) MAPK1SYKCDK2KDM4EGAA
SCHEMBL24220845 0.71 MAPK1 (0.68) MAPK1CDK2KDM4EGAAHDAC3
SCHEMBL17973022 0.71 MAPK1 (0.68) MAPK1CCNKCDK12KDM4EGAA
SCHEMBL23933469 0.70 KDM1A (0.41) KDM1AJAK2JAK1CHRNB2CHRNA4
SCHEMBL23933466 0.70 KDM1A (0.41) KDM1AJAK2JAK1CHRNB2CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183219-A1 CONDENSED SUBSTITUTED HYDROPYRROLES AS ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY 2023-06-15 — — US disclosed
US-20230183218-A1 CONDENSED SUBSTITUTED HYDROPYRROLES AS ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY 2023-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183218-A1 CONDENSED SUBSTITUTED HYDROPYRROLES AS ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 CHRM3, CHRM2, CHRM4 MAPK1 4327/4885KDM1A 2507/4885JAK2 2304/4885
US-20230183219-A1 CONDENSED SUBSTITUTED HYDROPYRROLES AS ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 CHRM3, CHRM2, CHRM4 MAPK1 4059/4885KDM1A 2152/4885JAK2 2464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback